Vext Science Inc (VV5) - Total Liabilities

Latest as of September 2025: €59.68 Million EUR ≈ $69.77 Million USD

Based on the latest financial reports, Vext Science Inc (VV5) has total liabilities worth €59.68 Million EUR (≈ $69.77 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of Vext Science Inc to see how much of total assets are deployed in long-term investments.

Vext Science Inc - Total Liabilities Trend (2017–2024)

This chart illustrates how Vext Science Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Vext Science Inc.

Vext Science Inc Competitors by Total Liabilities

The table below lists competitors of Vext Science Inc ranked by their total liabilities.

Company Country Total Liabilities
Kronologi Asia Bhd
KLSE:0176
Malaysia RM111.87 Million
Destini Bhd
KLSE:7212
Malaysia RM223.38 Million
KMH Hitech Co. Ltd
KQ:052900
Korea ₩79.08 Billion
Rand Capital Corp
NASDAQ:RAND
USA $958.27K
Yoo Sung Ent
KO:002920
Korea ₩134.34 Billion
Level Biotechnology
TWO:3118
Taiwan NT$237.03 Million
Elektrocieplownia Bedzin
WAR:BDZ
Poland zł9.97 Million
Anli International Co Ltd
TWO:5223
Taiwan NT$1.33 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Vext Science Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Vext Science Inc (VV5) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.87 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.47 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vext Science Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vext Science Inc (2017–2024)

The table below shows the annual total liabilities of Vext Science Inc from 2017 to 2024.

Year Total Liabilities Change
2024-12-31 €61.23 Million
≈ $71.59 Million
+12.19%
2023-12-31 €54.58 Million
≈ $63.81 Million
+12.30%
2022-12-31 €48.60 Million
≈ $56.82 Million
+99.91%
2021-12-31 €24.31 Million
≈ $28.42 Million
+27.00%
2020-12-31 €19.14 Million
≈ $22.38 Million
+46.04%
2019-12-31 €13.11 Million
≈ $15.32 Million
+103.73%
2018-12-31 €6.43 Million
≈ $7.52 Million
+26.99%
2017-12-31 €5.07 Million
≈ $5.92 Million
--

About Vext Science Inc

F:VV5 Germany Drug Manufacturers - Specialty & Generic
Market Cap
$32.36 Million
€27.68 Million EUR
Market Cap Rank
#23596 Global
#2049 in Germany
Share Price
€0.15
Change (1 day)
+2.05%
52-Week Range
€0.06 - €0.22
All Time High
€1.26
About

Vext Science, Inc., through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. The company al… Read more